HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Mark Parsons Selected Research

Mark Parsons Research Topics

Disease

15Stroke (Strokes)
10/2015 - 01/2005
1Urinary Tract Infections (Urinary Tract Infection)
10/2015
1Dehydration (Water Stress)
10/2015
1Hematoma
10/2015
1Cerebral Hemorrhage
10/2015
1Brain Edema (Cerebral Edema)
10/2015
1Intracranial Hemorrhages (Intracranial Hemorrhage)
08/2015
1Infarction
07/2013
1Body Weight (Weight, Body)
03/2012
1Wounds and Injuries (Trauma)
08/2011
1Hemorrhage
01/2010
1Myocardial Infarction
01/2005
1Paralysis (Palsy)
04/2004
1Hypokalemia
04/2004
1Renal Tubular Acidosis (Distal Renal Tubular Acidosis)
04/2004

Drug/Important Bio-Agent (IBA)

7Tissue Plasminogen Activator (Alteplase)FDA Link
08/2015 - 07/2007
24- Acetamido- 4'- isothiocyanatostilbene- 2,2'- disulfonic Acid (SITS)IBA
11/2014 - 09/2010
2Cytidine Triphosphate (CTP)IBA
01/2014 - 07/2013
1CreatinineIBA
10/2015
1Mannitol (Osmitrol)FDA LinkGeneric
10/2015
1tenecteplaseFDA Link
03/2012
1Glucose (Dextrose)FDA LinkGeneric
05/2010
1Biological Markers (Surrogate Marker)IBA
08/2009
1Glycoproteins (Glycoprotein)IBA
06/2008
1Factor VII (Proconvertin)IBA
06/2008
1Plasminogen Activators (Plasminogen Activator)IBA
07/2007
1Plasminogen Activator Inhibitor 1IBA
07/2007
1CholesterolIBA
01/2005
1PotassiumIBA
04/2004

Therapy/Procedure

1Aftercare (After-Treatment)
11/2014
1Musculoskeletal Manipulations (Manipulative Therapy)
08/2011
1Thrombolytic Therapy
02/2005